Two CIC bioGUNE research projects on Covid-19, adjudged by the Provincial Council of Bizkaia to be priority activities for patronage
Two CIC bioGUNE research projects on Covid-19, adjudged by the Provincial Council of Bizkaia to be priority activities for patronage
The projects deemed as priority are the development and validation of scalable serological tests for identifying seropositive Covid-19 patients, and the development of tools for serological SARS-CoV-2 diagnosis in the general public.
Funding organisations and/or individuals are eligible for a 45% tax reduction on corporate or personal income tax.
(Bilbao, 4 November 2020). Two research projects on Covid-19 conducted by CIC bioGUNE - a member of the Basque Research & Technology Alliance BRTA - have been adjudged by the Provincial Council of Bizkaia to be priority activities for patronage. The projects selected as priority are focused on the development and validation of scalable serological tests for identifying seropositive Covid-19 patients, and the development of analytical tools and metabolomics for serological SARS-CoV-2 diagnosis in the general public.
This decision provides organisations and individuals with the opportunity to obtain tax deductions if they are interested in contributing to the funding of the above-mentioned projects. The form this collaboration may take and the publicity to be given to the involvement of the funder in these projects is flexible.
In accordance with local government regulation, funding organisations or individuals will be eligible to deduct up to 45% of their income tax or corporate tax for the amounts allocated to the projects. Both taxpayers subject to Bizkaia tax regulations and non-resident taxpayers operating with a permanent establishment and subject to Bizkaia tax regulations are eligible.
About CIC bioGUNE
The Centre for Cooperative Research in Biosciences (CIC bioGUNE), located in the Bizkaia Technology Park, is a biomedical research organisation conducting cutting-edge research at the interface between structural, molecular and cell biology, with a particular focus on generating knowledge on the molecular bases of disease, for use in the development of new diagnostic methods and advanced therapies. CIC bioGUNE has been accredited as a “Severo Ochoa Centre of Excellence”, the highest level of recognition for centres of excellence in Spain.
About BRTA
The BRTA is an alliance made up of 4 collaborative research centres (CIC bioGUNE, CIC nanoGUNE, CIC biomaGUNE y CIC energiGUNE) and 12 technology centres (Azterlan, Azti, Ceit, Cidetec, Gaiker, Ideko, Ikerlan, Lortek, Neiker, Tecnalia, Tekniker y Vicometch), with the aim of developing advanced technological solutions for Basque companies.
With the support of the Basque Government, the SPRI Group and the Provincial Councils of the three regional provinces, the alliance seeks to promote collaboration among its centres, to strengthen the conditions to generate and transfer knowledge to companies, contributing to their competitiveness, and to spread Basque scientific and technological capacity outside of the Basque Country.
BRTA has a staff of 3,500, accounts for 22% of the Basque Country’s R&D investment, has an annual turnover of over EUR 300 million and files 100 European and international patents per year.